carbinoxamine
CHEBI:CHEBI_3398
Definition
An organochlorine compound that is 2-(4-chlorobenzyl)pyridine in which one of the benzylic hydrogens is substituted by 2-(dimethylamino)ethoxy group. It is an ethanolamine-type antihistamine, used as its maleate salt for treating hay fever, as well as mild cases of Parkinson's disease.
Chemical Information
- Molecular Formula
- C16H19ClN2O
- Molecular Mass
- 290.78800
- Charge
- 0
- SMILES
- CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1
- InChI
- InChI=1S/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3
- InChIKey
- OJFSXZCBGQGRNV-UHFFFAOYSA-N
Alternative Names
- (+-)-carbinoxamine
- {2-[(4-Chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine
- 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine
- 2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]-N,N-dimethylethanamine
- carbinoxamina
- carbinoxamine
- Carbinoxamine
- carbinoxamine base
- carbinoxaminum
- paracarbinoxamine
Treatment Applications
-
obsolete trivittatus encephalitisView Disease →
DOID:0050172
-
Venezuelan equine encephalitisView Disease →
DOID:9584
Drug Classification
-
pyridinesView Class →
CHEBI:26421
-
tertiary amino compoundView Class →
CHEBI:50996
-
monochlorobenzenesView Class →
CHEBI:83403
-
t192735
-
t193009
-
t193017
-
t193365
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:3398
- DRON_00010000
- 20220
- oboInOwl#hasDbXref
- Wikipedia:Carbinoxamine
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- core#notation
- CHEBI:3398
- rxcui
- 1869883
- pharm_class
- Histamine-1 Receptor Antagonist [EPC]
- active_ingredient_strength
- 4 mg/5mL
- package_marketing_start_date
- 20121210
- manufacturer_name
- Neos Therapeutics LP
- active_ingredient_name
- CARBINOXAMINE MALEATE
- package_description
- 480 mL in 1 BOTTLE, PLASTIC (62542-101-05)
- unii
- 02O55696WH
- spl_set_id
- 199f46e5-6288-5627-e063-6294a90ae086
- upc
- 0362542101059
- package_ndc
- 73684-110-60
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 20220
- oboInOwl#hasDbXref
- Wikipedia:Carbinoxamine
- oboInOwl#hasAlternativeId
- CHEBI:166273
- oboInOwl#id
- CHEBI:3398
- product_type
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- route
- ORAL
- dosage_form
- SUSPENSION, EXTENDED RELEASE
- marketing_category
- BULK INGREDIENT
- marketing_start_date
- 20121210
- labeler_name
- Neos Therapeutics LP
- generic_name
- carbinoxamine maleate
- brand_name
- Carbinoxamine Maleate Extended-Release Oral Suspension
- brand_name_base
- Carbinoxamine Maleate Extended-Release Oral Suspension
- product_ndc
- 62542-101
- spl_id
- 199f46e5-6289-5627-e063-6294a90ae086
- application_number
- NDA022556
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_37955
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- owl#someValuesFrom
- t885848
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_113732
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect20673
- owl#annotatedSource
- t194013